Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 12/20 | 0.52 |
| ▸ | CNR2 | P34972 | 5/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8093828 | 0.87 | CNR1 (0.52) | CNR1CNR2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL8776749 | 0.81 | PTGS2 (0.47) | CNR1CNR2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL2932218 | 0.80 | CNR1 (0.49) | CNR1CNR2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL8087025 | 0.78 | PTGS2 (0.54) | — | |
| SCHEMBL19835709 | 0.75 | CNR1 (0.55) | CNR1CNR2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL8100978 | 0.73 | CNR1 (0.47) | CNR1CNR2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL8085631 | 0.73 | CNR1 (0.52) | CNR1CNR2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL13498508 | 0.72 | NPSR1 (0.69) | CNR1CNR2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL2932221 | 0.72 | RPS6KA3 (0.40) | CNR1CNR2CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL5904231 | 0.72 | CNR1 (0.56) | CNR1CNR2CYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0808304-A1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1997-11-26 | — | — | EP | disclosed |
| WO-1996024584-A1 | 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-08-15 | — | — | WO | disclosed |